Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Хроническое воспаление жировой ткани, связывающее ожирение с инсулинорезистентностью и сахарным диабетом 2 типа
2020-01-29
SCID: 54.1/88ek6t62
Discuss with AI
adipose tissue inflammationadipose tissue macrophagesinsulin resistanceobesity-related metabolic complicationstype 2 diabetes
Figures from the paper
Abstract (AI)
Obesity is one of the major health burdens of the 21st century as it contributes to the growing prevalence of its related comorbidities, including insulin resistance and type 2 diabetes. Growing evidence suggests a critical role for overnutrition in the development of low-grade inflammation. Specifically, chronic inflammation in adipose tissue is considered a crucial risk factor for the development of insulin resistance and type 2 diabetes in obese individuals. The triggers for adipose tissue inflammation are still poorly defined. However, obesity-induced adipose tissue expansion provides a plethora of intrinsic signals (e.g., adipocyte death, hypoxia, and mechanical stress) capable of initiating the inflammatory response. Immune dysregulation in adipose tissue of obese subjects results in a chronic low-grade inflammation characterized by increased infiltration and activation of innate and adaptive immune cells. Macrophages are the most abundant innate immune cells infiltrating and accumulating into adipose tissue of obese individuals; they constitute up to 40% of all adipose tissue cells in obesity. In obesity, adipose tissue macrophages are polarized into pro-inflammatory M1 macrophages and secrete many pro-inflammatory cytokines capable of impairing insulin signaling, therefore promoting the progression of insulin resistance. Besides macrophages, many other immune cells (e.g., dendritic cells, mast cells, neutrophils, B cells, and T cells) reside in adipose tissue during obesity, playing a key role in the development of adipose tissue inflammation and insulin resistance. The association of obesity, adipose tissue inflammation, and metabolic diseases makes inflammatory pathways an appealing target for the treatment of obesity-related metabolic complications. In this review, we summarize the molecular mechanisms responsible for the obesity-induced adipose tissue inflammation and progression toward obesity-associated comorbidities and highlight the current therapeutic strategies.
Key Findings
1
Adipose tissue macrophages become polarized toward a pro-inflammatory M1 state and release cytokines that impair insulin signaling and promote insulin resistance.
2
Chronic low-grade inflammation in adipose tissue is identified as a crucial link between obesity, insulin resistance, and type 2 diabetes.
3
Multiple immune cell types, including dendritic cells, mast cells, neutrophils, B cells, and T cells, contribute to adipose inflammation and metabolic dysfunction, making inflammatory pathways therapeutic targets.
4
Obesity causes infiltration and activation of innate and adaptive immune cells in adipose tissue, with macrophages comprising up to 40% of adipose tissue cells.
5
Obesity-driven adipose tissue expansion generates intrinsic inflammatory signals, including adipocyte death, hypoxia, and mechanical stress, although precise triggers remain poorly defined.
Research Object
Obesity-associated adipose tissue and its immune-cell environment
Research Subject
Molecular mechanisms by which chronic adipose tissue inflammation promotes insulin resistance and type 2 diabetes
Publication Details
Publication Date
2020-01-29
Journal
Publisher
ISSN
Cited by
1422
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest